Skip to main content
Log in

Synthesis and Anticonvulsive Activity of 3- and 4-Benzoylpyridine Oxime Derivatives

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

We present here the synthesis of 3- and 4-benzoylpyridine oxime derivatives with potential anticonvulsant action. The most active compound in the maximum electric shock test was 4-benzoylpyridine O-2-morpholinoethyloxime oxalate (1a), i.p. doses of 60 – 150 mg/kg of which increased the survival of mice to 100%. The best effect in the corasol antagonism test was obtained with 4-benzoylpyridine O-(isonicotinoyl)oxime (2c), i.p. doses of 12.5 mg/kg of which increased the survival of mice to 67% and the latent period of onset of generalized tonic-clonic convulsions to 52 sec. Compound 1a had low toxicity (the i.p. LD50 in mice was 316 mg/kg) and a therapeutic index of 21.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. V. A. Karlov, Epilepsy in Children and Adult Women and Men: Guidelines for Doctors [in Russian], Meditsina, Moscow (2010).

    Google Scholar 

  2. R. D. Porter and B. S. Meldrum, “Antiseizure drugs”, in: Basic and Clinical Pharmacology [Russian translation], B. G. Katzung (ed.), Binom, Moscow and Dialekt, St. Petersburg (2007), Vol. 1, pp. 464 – 491.

    Google Scholar 

  3. D. Periiig, D. Š. Štrac, and J. Vlainig, J. Neural Transmission, 113(12), 1863 – 1871 (2006).

    Article  Google Scholar 

  4. E. Favale, V. Rubino, P. Mainardi, et al., Neurology, 45(10), 1926 – 1927 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. S. L. Lee, B. B. Williams, and M. M. Kochhar, J. Pharm. Sci., 54, 393 (1965).

    Article  Google Scholar 

  6. O. M. Glozman, L. A. Zhmurenko, L. M. Meshcheryakova, et al., Khim.-Farm. Zh., 21(9), 1059 – 1063 (1987); Pharm. Chem. J., 21(9), 624 – 629 (1987).

  7. V. P. Lezina, S. G. Rozenberg, O. M. Glozman, et al., Khim. Geterotsikl. Soedin., 8, 1073 – 1077 (1990).

    Google Scholar 

  8. J. A. van Zorge, Patent US 4297359 (1981).

  9. T. A. Voronina and L. N. Nerobkova, Methodological Recommendations for the Study of the Anticonvulsant Activity of Pharmacological Substances. Guidelines for Preclinical Studies of Medicines [in Russian], Scientific Center for Expert Evaluation of Medicinal Products, Grifi K, Moscow (2012), pp. 235 – 250.

  10. W. Loscher, C. P. Fassbender, and B. Nolting, Epilepsy Res., 8(2), 79 – 94 (1991).

    Article  CAS  PubMed  Google Scholar 

  11. E. A. Swinyard, Epilepsia, 10, 107 – 119 (1969).

    Article  CAS  PubMed  Google Scholar 

  12. W. Loscher, D. Honack, C. P. Fassbender, and B. Nolting, Epilepsy Res., 8, 171 – 189 (1991).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. V. Mokrov.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 1, pp. 19 – 28, January, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhmurenko, L.A., Voronina, T.A., Litvinova, S.A. et al. Synthesis and Anticonvulsive Activity of 3- and 4-Benzoylpyridine Oxime Derivatives. Pharm Chem J 52, 42–51 (2018). https://doi.org/10.1007/s11094-018-1763-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-018-1763-z

Keywords

Navigation